A detailed history of Petix & Botte CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Petix & Botte CO holds 3,496 shares of MRK stock, worth $340,650. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,496
Previous 3,496 -0.0%
Holding current value
$340,650
Previous $432,000 8.1%
% of portfolio
0.11%
Previous 0.12%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $216,402 - $232,414
1,748 Added 100.0%
3,496 $432,000
Q1 2024

May 03, 2024

SELL
$113.24 - $131.95 $197,943 - $230,648
-1,748 Reduced 50.0%
1,748 $230,000
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $10,295 - $11,433
100 Added 2.94%
3,496 $359,000
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $368,839 - $402,018
3,396 New
3,396 $391,000
Q2 2022

Aug 04, 2022

SELL
$83.49 - $94.64 $255,813 - $289,976
-3,064 Closed
0 $0
Q1 2022

Apr 26, 2022

BUY
$73.51 - $82.4 $225,234 - $252,473
3,064 New
3,064 $251,000
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $221,465 - $277,414
-3,064 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $219,627 - $241,535
3,064 New
3,064 $231,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Petix & Botte CO Portfolio

Follow Petix & Botte CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petix & Botte CO, based on Form 13F filings with the SEC.

News

Stay updated on Petix & Botte CO with notifications on news.